• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病、多系统萎缩和进行性核上性麻痹中黑质蛋白酶体亚单位表达变化的比较。

A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

机构信息

School of Health and Biomedical Sciences, King's College, London, UK.

出版信息

Brain Res. 2010 Apr 22;1326:174-83. doi: 10.1016/j.brainres.2010.02.045. Epub 2010 Feb 20.

DOI:10.1016/j.brainres.2010.02.045
PMID:20176003
Abstract

Dysfunction of the ubiquitin-proteasome system (UPS) occurs in dopaminergic neurones in the SN in PD and it is associated with Lewy body formation. However, it remains unknown whether this is specific to PD or whether it also occurs in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) where nigral dopaminergic neurones also degenerate. In the present study, we investigated changes in the expression of proteasomal subunits in the SN in PD, MSA and PSP. Immunohistochemistry double staining showed that proteasome 20S-alpha4 and -alpha6, and 20S-beta3 and -beta5i subunits are colocalized with tyrosine hydroxylase (TH)-positive cells in the SN of control, PD, MSA and PSP brain. Semi-quantitative analysis showed a significant loss of 20S-alpha4 and -alpha6 subunits TH-positive cells in PD, MSA and PSP compared to control tissue. There was no change in the expression of 20S-beta3 and -beta5i subunits in any of the disease states. The expression of PA700-Rpt5 subunits was not changed in PSP or PD but was significantly increased in MSA compared to control SN. PA700-Rpn10 subunit was not colocalized with TH within dopamine cells but was co-expressed with glial fibrillary acid protein (GFAP) positive astrocytes in the SN of all groups. PA28-alpha immunoreactivity was low in TH positive neurones in control tissue and quantification was not possible. Qualitative analysis suggested a decrease in PD and no immunoreactivity was detected in MSA or PSP. The results show that changes in proteasomal structure occur in the SN in PD, MSA and PSP and that these are similar in nature suggesting that dysfunction of UPS is not specific to PD or to Lewy body formation.

摘要

泛素-蛋白酶体系统(UPS)的功能障碍发生在 PD 患者的 SN 中的多巴胺能神经元中,并且与路易体形成有关。然而,目前尚不清楚这种情况是否是 PD 所特有的,还是也发生在多系统萎缩(MSA)和进行性核上性麻痹(PSP)中,其中黑质多巴胺能神经元也会退化。在本研究中,我们研究了 PD、MSA 和 PSP 中 SN 中蛋白酶体亚基表达的变化。免疫组织化学双重染色显示,蛋白酶体 20S-α4 和-α6 以及 20S-β3 和-β5i 亚基与 SN 中的酪氨酸羟化酶(TH)阳性细胞共定位。半定量分析显示,与对照组相比,PD、MSA 和 PSP 中的 20S-α4 和-α6 亚基 TH 阳性细胞明显减少。在任何疾病状态下,20S-β3 和-β5i 亚基的表达都没有变化。PA700-Rpt5 亚基在 PSP 或 PD 中没有变化,但在 MSA 中与对照组相比显著增加。PA700-Rpn10 亚基与多巴胺细胞内的 TH 没有共定位,但在所有组的 SN 中与胶质纤维酸性蛋白(GFAP)阳性星形胶质细胞共表达。PA28-α 在对照组组织中 TH 阳性神经元中的免疫反应性较低,无法进行定量分析。定性分析表明 PD 减少,而 MSA 或 PSP 中则没有免疫反应性。结果表明,在 PD、MSA 和 PSP 中 SN 中的蛋白酶体结构发生变化,其性质相似,表明 UPS 功能障碍不仅是 PD 所特有的,也不仅与路易体形成有关。

相似文献

1
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.帕金森病、多系统萎缩和进行性核上性麻痹中黑质蛋白酶体亚单位表达变化的比较。
Brain Res. 2010 Apr 22;1326:174-83. doi: 10.1016/j.brainres.2010.02.045. Epub 2010 Feb 20.
2
MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.用1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)处理普通狨猴会损害蛋白酶体酶活性,并降低26S蛋白酶体结构和调节元件的表达。
Eur J Neurosci. 2006 Apr;23(7):1766-74. doi: 10.1111/j.1460-9568.2006.04718.x.
3
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
4
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.在病程较长的帕金森病中存在胶质细胞病变,但黑质神经元无凋亡。
Mov Disord. 1998 Mar;13(2):221-7. doi: 10.1002/mds.870130205.
5
Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.进行性核上性麻痹会影响黑质致密部和网状部。
Exp Neurol. 1997 Mar;144(1):183-92. doi: 10.1006/exnr.1997.6415.
6
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.与帕金森病相比,进行性核上性麻痹和多系统萎缩患者脑脊液中神经丝蛋白水平升高。
Mov Disord. 1998 Jan;13(1):70-7. doi: 10.1002/mds.870130116.
7
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.黑质谷胱甘肽缺乏并非特发性帕金森病所特有。
Mov Disord. 2003 Sep;18(9):969-76. doi: 10.1002/mds.10486.
8
Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.帕金森病中溶酶体和蛋白酶体标志物的改变:与α-突触核蛋白包涵体的关系。
Neurobiol Dis. 2009 Sep;35(3):385-98. doi: 10.1016/j.nbd.2009.05.023. Epub 2009 Jun 6.
9
Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.进行性核上性麻痹与帕金森病变异型多系统萎缩脑铁沉积的解剖部位差异。
J Neurol Sci. 2013 Feb 15;325(1-2):29-35. doi: 10.1016/j.jns.2012.11.009. Epub 2012 Dec 20.
10
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.帕金森病、进行性核上性麻痹和多系统萎缩的脑萎缩模式。
Parkinsonism Relat Disord. 2011 Mar;17(3):172-6. doi: 10.1016/j.parkreldis.2010.12.010. Epub 2011 Jan 13.

引用本文的文献

1
Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.帕金森病中的神经退行性变模型:神经元死亡的细胞和分子途径。
Behav Brain Funct. 2025 May 31;21(1):14. doi: 10.1186/s12993-025-00279-w.
2
Immune cell metabolic dysfunction in Parkinson's disease.帕金森病中的免疫细胞代谢功能障碍
Mol Neurodegener. 2025 Mar 24;20(1):36. doi: 10.1186/s13024-025-00827-y.
3
Fibrinogen degradation products exacerbate alpha-synuclein aggregation by inhibiting autophagy via downregulation of Beclin1 in multiple system atrophy.
纤维蛋白原降解产物通过下调多系统萎缩中Beclin1抑制自噬,从而加剧α-突触核蛋白聚集。
Neurotherapeutics. 2025 Mar;22(2):e00538. doi: 10.1016/j.neurot.2025.e00538. Epub 2025 Feb 4.
4
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease.在帕金森病蛋白酶体抑制小鼠模型中,烟酰胺核糖苷最初可缓解症状,但随后会下调多巴胺代谢。
Heliyon. 2024 Jul 9;10(14):e34355. doi: 10.1016/j.heliyon.2024.e34355. eCollection 2024 Jul 30.
5
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.帕金森病中的线粒体功能障碍——具有治疗潜力的关键疾病标志。
Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7.
6
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.神经退行性疾病中的小胶质细胞:机制与潜在治疗靶点。
Signal Transduct Target Ther. 2023 Sep 22;8(1):359. doi: 10.1038/s41392-023-01588-0.
7
Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools.环境污染物诱导的神经退行性蛋白质病:热休克蛋白和蛋白酶体作为有前景的治疗工具
Pharmaceutics. 2023 Jul 30;15(8):2048. doi: 10.3390/pharmaceutics15082048.
8
The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease.蛋白酶体:神经系统功能、大脑衰老和神经退行性疾病的关键调节因子。
Front Cell Dev Biol. 2023 Apr 13;11:1124907. doi: 10.3389/fcell.2023.1124907. eCollection 2023.
9
A Mouse Model of Multiple System Atrophy: Bench to Bedside.多系统萎缩症的小鼠模型:从基础到临床。
Neurotherapeutics. 2023 Jan;20(1):117-126. doi: 10.1007/s13311-022-01287-8. Epub 2022 Aug 22.
10
Neuroprotective Potency of Neolignans in Cortex Against Brain Disorders.新木脂素对大脑皮层预防脑部疾病的神经保护作用。
Front Pharmacol. 2022 Jun 16;13:857449. doi: 10.3389/fphar.2022.857449. eCollection 2022.